Hello allSeveral posters have noted that from a technical view...

Hello all

Several posters have noted that from a technical view PSD may retrace to the 70 cent level. I am not a technical trader so I will not support or refute this claim. The point I want to make is that PSD is currently conducting Phase IIa human clinical trials for Brachysil in Singapore, with interim results due in early October. From a fundamental perspective PSD has little down side at the moment. I spoke to the company yesterday and the trials are going as expected. I would expect some buying in the lead up to the release of the interim results in early october.

My opinion only

Cheers

Doyle